Early Prediction of Treatment Efficacy in Second-Stage Gambiense Human African Trypanosomiasis

Open Access

Peer-reviewed

Research Article

Gerardo Priotto ,

* E-mail: gpriotto@neuf.fr (GP); jean-francois.etard@epicentre.msf.org (JE)

Affiliation Epicentre, Paris, France
⨯
François Chappuis,

Affiliation Operational Centre Geneva, Médecins sans Frontiéres, Geneva University Hospitals, Geneva, Switzerland
⨯
Mathieu Bastard,

Affiliation Epicentre, Paris, France
⨯
Laurence Flevaud,

Affiliation Operational Centre Barcelona-Athens, Médecins sans Frontiéres, Barcelona, Spain
⨯
Jean-François Etard

* E-mail: gpriotto@neuf.fr (GP); jean-francois.etard@epicentre.msf.org (JE)

Affiliations Epicentre, Paris, France, Institut de Recherche pour le Développement/UMI 233, Montpellier, France
⨯

Reader Comments (0)

White blood cells
Is the Subject Area "White blood cells" applicable to this article?

Thanks for your feedback.
Trypanosoma
Is the Subject Area "Trypanosoma" applicable to this article?

Thanks for your feedback.
Algorithms
Is the Subject Area "Algorithms" applicable to this article?

Thanks for your feedback.
Cerebrospinal fluid
Is the Subject Area "Cerebrospinal fluid" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Trypanosomiasis
Is the Subject Area "Trypanosomiasis" applicable to this article?

Thanks for your feedback.
African trypanosomiasis
Is the Subject Area "African trypanosomiasis" applicable to this article?

Thanks for your feedback.